Cardlytics Stock Investor Sentiment

CDLX Stock  USD 3.06  0.10  3.16%   
Slightly above 72% of Cardlytics' investor base is looking to short. The current sentiment regarding investing in Cardlytics stock implies that many traders are alarmed. Cardlytics' investing sentiment can be driven by a variety of factors including economic data, Cardlytics' earnings reports, geopolitical events, and overall market trends.
  
over three months ago at accesswire.com         
Acquisition by Sosin Clifford of 350000 shares of Cardlytics at 14.1601 subject to Rule 16b-3
news
over three months ago at accesswire.com         
CDLX ALERT- Levi Korsinsky Has Commenced an Investigation on Behalf of Cardlytics, Inc. Shareholders...
news
over three months ago at accesswire.com         
Shareholders With Losses In Cardlytics Inc. Are Encouraged To Participate In Securities Fraud Case W...
news
over three months ago at accesswire.com         
Cardlytics, Inc. Investors with Losses are Urged to Contact Levi Korsinsky to Discuss Their Rights
news
over three months ago at accesswire.com         
Did Cardlytics, Inc. Mislead Investors Shareholder Rights Advocates at Levi Korsinsky Investigate - ...
news
over three months ago at accesswire.com         
Acquisition by Amit Gupta of 500000 shares of Cardlytics subject to Rule 16b-3
news
over three months ago at accesswire.com         
Cardlytics, Inc. Investigation Ongoing Contact Levi Korsinsky About Potential Securities Fraud Alleg...
news
over three months ago at accesswire.com         
Investors With Losses In Cardlytics Inc. Invited To Join The Schall Law Firm In Securities Fraud Cas...
news
over three months ago at accesswire.com         
Investors who lost money on Cardlytics, Inc. should contact Levi Korsinsky about an ongoing investig...
news
over three months ago at accesswire.com         
Cardlytics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi Korsin...
news
over three months ago at globenewswire.com         
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635
Macroaxis News: globenewswire.com
over three months ago at finance.yahoo.com         
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635
Yahoo News
over three months ago at benzinga.com         
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635
benzinga news
over three months ago at benzinga.com         
Cardlytics Under Investor Scrutiny About Growth Initiatives Hagens Berman
benzinga news
over three months ago at accesswire.com         
Cardlytics, Inc. Investigated by Shareholder Rights Advocates Investors Should Contact Levi Korsinsk...
news
Far too much social signal, news, headlines, and media speculation about Cardlytics that are available to investors today. That information is available publicly through Cardlytics media outlets and privately through word of mouth or via Cardlytics internal channels. However, regardless of the origin, that massive amount of Cardlytics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cardlytics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cardlytics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cardlytics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cardlytics alpha.

Cardlytics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Hornsey Liane of 1326 shares of Cardlytics subject to Rule 16b-3
11/12/2024
2
Disposition of 43750 shares by Alexis DeSieno of Cardlytics subject to Rule 16b-3
11/14/2024
3
Disposition of 25118 shares by Alexis DeSieno of Cardlytics at 3.43 subject to Rule 16b-3
11/15/2024
4
Disposition of 19523 shares by Sosin Clifford of Cardlytics at 3.953 subject to Rule 16b-3
12/03/2024
5
Disposition of 2700000 shares by Sosin Clifford of Cardlytics subject to Rule 16b-3
12/19/2024
6
Parsons Stock Gains 49 percent in a Year What Should Investors Do Now
12/27/2024
7
Disposition of 15650 shares by Sosin Clifford of Cardlytics at 3.7784 subject to Rule 16b-3
12/30/2024
8
Disposition of 14349 shares by Amit Gupta of Cardlytics subject to Rule 16b-3
12/31/2024
9
Disposition of 5964 shares by Amit Gupta of Cardlytics at 3.667 subject to Rule 16b-3
01/03/2025
10
Cardlytics CEO Amit Gupta sells 21,869 in stock - Investing.com
01/06/2025
11
At US3.35, Is It Time To Put Cardlytics, Inc. On Your Watch List
01/10/2025
12
Cardlytics, Inc. Investors Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
01/15/2025
13
Securities Fraud Investigation Into Cardlytics, Inc. Announced Investors Who Lost Money Urged To Contact Glancy Prongay Murray LLP, a Leading Securities Fraud L...
01/16/2025
14
Disposition of 43750 shares by Amit Gupta of Cardlytics subject to Rule 16b-3
01/23/2025
15
Disposition of 15160 shares by Amit Gupta of Cardlytics at 3.92 subject to Rule 16b-3
01/24/2025
16
Cardlytics, Inc. Class Action Alert Wolf Haldenstein Adler - GlobeNewswire
01/30/2025

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.